In 2010, the Federal Drug Enforcement Administration (DEA) published an interim final rule as to what vendors and healthcare organizations need to do to support Electronic Prescribing of Controlled Substances. Since that time many vendors have updated their solutions to meet these requirements and EPCS has been steadily gaining momentum, with mandates at the state and national levels.
Read this whitepaper which simplifies the DEA ruling and identifies areas to focus your planning to have a successful DEA compliant EPCS roll-out.